News
The funding comes more than a year after the company closed an oversubscribed $31.4 million Series B round.
The Series B extension brings the round to $35 million, raising Hyro's total funding to $50 million.
The company will use the funds to enhance its R&D strategy, advance its SEEDIT platform and boost product development.
Sameer Sethi, senior vice president and chief AI and insights officer at Hackensack Meridian Health joined MobiHealthNews to discuss the health system's plans for AI spending in 2025.
The company will use the funds to accelerate the commercialization of its TAPS therapy and enhance the visibility of its offerings among providers and patients.
The partnership will link advanced remote patient monitoring technology with virtual maternity services.
Former HealthTap employees allege that Mohr Davidow Ventures and company leaders stripped them of equity to position the company for a profitable turnaround benefiting MDV.
The company will use the funds to expand its commercial growth and clinical-evidence generation.
The aim is to provide AI-powered cancer risk prediction and independent report generation to help clinicians detect cancer.
The company aims to empower physicians with job transparency, financial tools and a peer community to enhance workplace fulfillment and autonomy.